Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Genetic vaccination" patented technology

Vaccines at Work. The merits of genetic immunization become most apparent when the actions of traditional vaccines are understood. Traditional preparations consist primarily of a killed or a weakened version of a pathogen (disease-causing agent) or of some piece (subunit) of the agent.

Artificial nucleic acid molecules for improved protein or peptide expression

ActiveUS12460204B2VectorsAntipyreticOpen reading framePeptide expression
The invention relates to an artificial nucleic acid molecule comprising at least one 5′ UTR element which is derived from a TOP gene, at least one open reading frame, and preferably at least one histone stem-loop. Optionally the artificial nucleic acid molecule may further comprise, e.g. a poly(A)sequence, a poyladenylation signal, and / or a 3′ UTR. The invention further relates to the use of such an artificial nucleic acid molecule in gene therapy and / or genetic vaccination.
Owner:CUREVAC SE

Engineered mRNA and use thereof

PendingUS20260185087A1MedicineGenetic vaccine
Provided are an engineered mRNA and a method for improving protein expression using same. Also provided is the use of such engineered mRNA in gene therapy and / or genetic vaccination.
Owner:XIANWEI (HAINAN) BIOTECHNOLOGY CO LTD

Artificial nucleic acid molecules for improved protein or peptide expression

PendingUS20260028627A1VectorsAntipyreticOpen reading framePeptide expression
The invention relates to an artificial nucleic acid molecule comprising at least one 5′UTR element which is derived from a TOP gene, at least one open reading frame, and preferably at least one histone stem-loop. Optionally the artificial nucleic acid molecule may further comprise, e.g. a poly(A)sequence, a poyladenylation signal, and / or a 3′UTR. The invention further relates to the use of such an artificial nucleic acid molecule in gene therapy and / or genetic vaccination.
Owner:CUREVAC SE